Κυριακή, 20 Μάιος 2012

Menu


FasL and FADD delivery by a glioma-specific and cell cycle-dependent HSV-1 amplicon virus enhanced apoptosis in primary human brain tumors
Τρίτη, 12 Οκτώβριος 2010 17:00    PDF Εκτύπωση E-mail
Αξιολόγηση Χρήστη: / 0
ΧείριστοΆριστο 
Conclusion: Taken together, our results showed that the glioma-specific and cell cycle-dependent HSV-1 amplicon vector is potentially useful as an adjuvant therapy to complement the current gene therapy strategy for gliomas. (Source: Molecular Cancer)

MedWorm Message: Watch the new MedWorm demo and find out how to get all the very latest, relevant, organized information daily!


Source: www.medworm.com
 

Μόσχευμα Ζωής Ε.Π.Ε.

Πιστοποίηση ISO

ISO

 

Ιδρυτικό Μέλος ΕΕΤΟΑ

ΕΕΤΟΑ

Διαπίστευση ΕΣΥΔ

Διαπίστευση ΕΣΥΔ

 

Ακολουθήστε Μας

Sitemap - Created by Ntinou